2026
conference-abstract
OpenAlex
Anil Tibdewal, Jai Prakash Agarwal, Guncha Maheshwari, R. Nabariya et autres
8624 Background: The timing of brain radiation therapy (RT) in patients with oncogene-mutated NSCLC with asymptomatic brain metastases (ABM) has been a matter of debate. No level 1 evidence supports delayed brain RT in ABM. This phase III, open-label, RCT (NCT05236946) evaluates …
in
(code pays fourni par la source)
2025
article
OpenAlex
Anil Tibdewal, P. Adole, Guncha Maheshwari, K. Prabhash et autres
us
(code pays fourni par la source)
2025
article
OpenAlex
Silva Sosa M, Anil Tibdewal, Guncha Maheshwari, G. Khatavkar et autres
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Anil Tibdewal, Prashasti SharmaDr, Guncha Maheshwari, Vanita Noronoha et autres
Abstract Background Unresectable Oesophageal squamous cell carcinoma confers a poor prognosis even after curative chemoradiotherapy. In this retrospective study, we have assessed the outcomes of oesophageal cancer with suspicious T4b disease treated with chemoradiotherapy. Methods From April 2018–2024, we included 100 histopathological …
in
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Sam David, Naveen Mummudi, Anil Tibdewal, Sabita Jiwnani et autres
PURPOSE: Neoadjuvant chemoradiotherapy has been established as the standard of care for locally advanced oesophageal cancers. Most of the evidences on neoadjuvant chemoradiotherapy (NACTRT) comes from the Western world where the predominant histology is adenocarcinoma. This study aimed to study the outcomes …
in
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
C.S. Pramesh, Rizwan Koita, Manju Sengar, Anthony Vipin Das et autres
Problem: Inefficient workflows, incomplete data and lack of interoperability can hinder the uptake of electronic records systems, challenges particularly relevant in cancer treatment with its complex longitudinal and multidisciplinary nature. Further, products developed in high-income countries are not designed for compatibility with …
in
(code pays fourni par la source)
2025
article
OpenAlex
Anil Tibdewal, R. Nabariya, Guncha Maheshwari, M Madhavi et autres
2025
article
OpenAlex
Minit Shah, Vanita Noronha, Srinivasan Kulandaivel, Bhavesh Poladia et autres
in
(code pays fourni par la source)
2024
article
OpenAlex
Vanita Noronha, Vijay Maruti Patil, Nandini Menon, Amit D. Joshi et autres
BACKGROUND: Standard neoadjuvant chemotherapy for locally advanced esophageal or gastroesophageal junction squamous cancer, 5-fluorouracil plus platinum, is toxic and logistically challenging; alternative regimens are needed. METHODS: This was a phase III randomized open-label noninferiority trial at Tata Memorial Center, India, in resectable …
in, gb
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
P. Adole, Anil Tibdewal, R. Mhatre, Pallavi P. Patwari et autres
in
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
P. Adole, Anil Tibdewal, R. Mhatre, Pallavi P. Patwari et autres
in
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Vanita Noronha, Atul Budukh, Pankaj Chaturvedi, Anne Srikanth et autres
Lung cancer varies between Caucasians and Asians. There have been differences recorded in the epidemiology, genomics, standard therapies and outcomes, with variations according to the geography and ethnicity which affect the decision for optimal treatment of the patients. To better understand the …
in, gb, pk, np, bd
(code pays fourni par la source)